ALNYLAM PHARMACEUTICALS, INC. Employee-related Liabilities, Current
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Employee-related Liabilities, Current of $257.20 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-02-12
- 2025-12-31: Employee-related Liabilities, Current $257.20M.
- 2024-12-31: Employee-related Liabilities, Current $214.40M.
- 2023-12-31: Employee-related Liabilities, Current $122.17M.
- 2022-12-31: Employee-related Liabilities, Current $130.69M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2025-12-31 | $257.20M 10-K · filed 2026-02-12 |
| 2024-12-31 | $214.40M 10-K · filed 2026-02-12 |
| 2023-12-31 | $122.17M 10-K · filed 2025-02-13 |
| 2022-12-31 | $130.69M 10-K · filed 2024-02-15 |
| 2021-12-31 | $93.58M 10-K · filed 2023-02-23 |
| 2020-12-31 | $97.43M 10-K · filed 2022-02-10 |
| 2019-12-31 | $68.30M 10-K · filed 2021-02-11 |
| 2018-12-31 | $37.30M 10-K · filed 2020-02-13 |
| 2017-12-31 | $33.83M 10-K · filed 2019-02-14 |
| 2016-12-31 | $13.69M 10-K · filed 2018-02-15 |
| 2015-12-31 | $11.16M 10-K · filed 2017-02-15 |
| 2014-12-31 | $7.36M 10-K · filed 2016-02-12 |
| 2013-12-31 | $4.82M 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |